Back

Manual Chest PRESSURE during Direct Current Cardioversion for Atrial Fibrillation: A Randomised Control Trial (PRESSURE-AF).

Ferreira, D.; Mikhail, P.; Lim, J.; Ray, M.; Dwivedi, J.; Brienesse, S.; Butel-Simoes, L.; Meere, W.; Bland, A.; Howden, N.; Malaty, M.; Kunda, M.; Kelty, A.; McGee, M.; Boyle, A.; Sverdlov, A. L.; William, M.; Attia, J.; Jackson, N.; Morris, G. M.; Barlow, M.; leitch, j.; Collins, N.; Ford, T. J.; Wilsmore, B.

2023-12-07 cardiovascular medicine
10.1101/2023.12.05.23299530
Show abstract

BackgroundDirect current cardioversion is frequently used to return patients with atrial fibrillation (AF) to sinus rhythm. Chest pressure during cardioversion may improve the efficacy of cardioversion through decreasing transthoracic impedance and increasing cardiac energy delivery. We aimed to assess the efficacy and safety of upfront chest pressure during direct current cardioversion for atrial fibrillation with anterior-posterior pad positioning. Design, Setting and ParticipantsThis was a multi-center, investigator-initiated, patient and analysis blinded, randomised clinical trial. Recruitment occurred from 2021 to 2023. Follow-up was until hospital discharge. Recruitment occurred across three centers in New South Wales, Australia. Inclusion criteria were age [≥]18, referred for cardioversion for AF, and anticoagulation for three weeks or transoesophageal echocardiography excluding left atrial appendage thrombus. Exclusion criteria were other arrhythmias requiring cardioversion, such as atrial flutter and atrial tachycardia. Intervention and OutcomesThe intervention arm received chest pressure during cardioversion from the first shock. The primary efficacy outcome was total joules required per patient encounter. Secondary efficacy outcomes included first shock success, transthoracic impedance, cardioversion success and sinus rhythm at 30 minutes post cardioversion. Results311 patients were randomised, 153 to control and 158 to intervention. There was no difference in total joules applied per encounter in the control arm versus intervention arm (356.4 {+/-} 301 vs 413.8 {+/-} 347, P=0.25). There was no difference in first shock success, total shocks provided, average impedance and cardioversion success. Conclusions and RelevanceThis study does not support the routine application of chest pressure for direct current cardioversion in atrial fibrillation. Reducing the complexity of cardioversion will improve the efficiency of the procedure for patients and healthcare systems. FundingNone to disclose Trial RegistrationACTRN12620001028998

Matching journals

1
BMJ Open
BMJ · based on 553 published papers
Top 8%
3.4× avg
2
Open Heart
BMJ · based on 18 published papers
#1
69× avg
3
Heart Rhythm
Elsevier BV · based on 16 published papers
Top 0.3%
72× avg
4
Heart
BMJ · based on 10 published papers
#1
119× avg
5
Circulation
Ovid Technologies (Wolters Kluwer Health) · based on 37 published papers
Top 0.9%
34× avg
6
The American Journal of Cardiology
Elsevier BV · based on 15 published papers
Top 1%
29× avg
7
Journal of the American Heart Association
Ovid Technologies (Wolters Kluwer Health) · based on 92 published papers
Top 6%
5.9× avg
8
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 77%
3.0%
9
BMC Cardiovascular Disorders
Springer Science and Business Media LLC · based on 11 published papers
Top 0.6%
30× avg
10
Frontiers in Cardiovascular Medicine
Frontiers Media SA · based on 33 published papers
Top 4%
6.5× avg
11
European Heart Journal
Oxford University Press (OUP) · based on 14 published papers
Top 4%
9.5× avg
12
International Journal of Cardiology
Elsevier BV · based on 13 published papers
Top 3%
13× avg
13
Journal of Clinical Medicine
MDPI AG · based on 77 published papers
Top 12%
2.3× avg
14
Hypertension
Ovid Technologies (Wolters Kluwer Health) · based on 20 published papers
Top 3%
7.6× avg
15
European Heart Journal - Digital Health
Oxford University Press (OUP) · based on 15 published papers
Top 3%
5.6× avg
16
European Journal of Preventive Cardiology
Oxford University Press (OUP) · based on 12 published papers
Top 2%
12× avg
17
Frontiers in Physiology
Frontiers Media SA · based on 18 published papers
Top 3%
6.8× avg
18
Frontiers in Pharmacology
Frontiers Media SA · based on 27 published papers
Top 4%
4.4× avg
19
Journal of Thrombosis and Haemostasis
Elsevier BV · based on 10 published papers
Top 2%
10× avg
20
Circulation: Genomic and Precision Medicine
Ovid Technologies (Wolters Kluwer Health) · based on 30 published papers
Top 6%
2.7× avg
21
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 87%
0.7%
22
Pilot and Feasibility Studies
Springer Science and Business Media LLC · based on 12 published papers
Top 2%
10× avg
23
BMJ
BMJ · based on 49 published papers
Top 8%
2.7× avg